1. Information about this Guideline – Colorectal Cancer

Office Leitlinienprogramm Onkologie
c/o Deutsche Krebsgesellschaft e. V.
Kuno-Fischer-Straße 80
14057 Berlin

leitlinienprogramm@krebsgesellschaft.de
www.leitlinienprogramm-onkologie.de

 

Leitlinienprogramm-Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Colorectal Cancer, Langversion 2.1, 2016, AWMF-Registernummer 032/024OL, https://www.leitlinienprogramm-onkologie.de/leitlinien/kolorektales-karzinom/

 

Medicine is continuously developing. Therefore, all information, especially diagnostic and therapeutic procedures, only corresponds to the knowledge at the time the guideline is printed. The greatest possible care was taken with the recommendations on therapy as well as choice and dose of drugs. Nonetheless, the users are requested to call on the manufacturer's instruction leaflet and the SmPC and in case of doubt to consult a specialist. In the OL-editors' general interest, relevant discrepancies should be reported.

The users are responsible for each diagnostic and therapeutic application, medication, and dosage.

In this guideline registered trademarks (protected trade names) have not been specifically marked. Therefore, it cannot be concluded from the missing of such a reference that it is a free trade name.

The copyright of the document is protected in all parts. Any use outside of the Copyright Protection Law is not allowed and illegal without written agreement of the German Guideline Program in Oncology (GGPO). No part of the document may be reproduced in any form without written permission of the GGPO. This holds in particular for copies, translations, microfiche, as well as the saving, use, and exploitation in electronic systems, intranets, and the internet.

 

This document is the long version of the evidenced-based Guideline Colorectal Cancer that is accessible via the following links:

• German Guideline Program in Oncology (https://www.leitlinienprogramm-onkologie.de/leitlinien/kolorektales-karzinom/)
• AWMF (http://www.awmf.org/leitlinien/detail/ll/021-007OL.html)
• Involved medical societies (e.g. https://www.dgvs.de/wissen-kompakt/leitlinien/leitlinien-der-dgvs/)
• Guidelines International Network (www.g-i-n.net)

In addition, the long version of this guideline will be published in the "Zeitschrift für Gastroenterologie".
Aside from the long version, the following complementary documents for this guideline exist:

• short version
• three patient guidelines concerning screening, early stage and advanced stage colorectal cancer (update currently in progress)
• guideline report
• translation (English)
• separate  evidence reports and publications (Screening, preoperative diagnostics, therapy for patients with metastases and in the palliative situation: Analysis of the use of angiogenesis inhibitors and anti-EGFR-antibodies for patients with metastasised CRC)

All these documents can also be accessed via the mentioned links.